Form 4 holding
President and CSO
Silverback Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 61,639
- Estimated value
- $233,180
- Report date
- 02 May 2022
- Price
- $3.78
- Ownership
- Direct
Valerie Odegard - President and CSO at ARS Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- President and CSO
- Issuer ticker
- SPRY on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Valerie Odegard since 28 Aug 2025
Reported holdings for Valerie Odegard in ARS Pharmaceuticals, Inc.
Form 4 holding
President and CSO
Silverback Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 90,467
- Estimated value
- Report date
- 02 May 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Valerie Odegard in ARS Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.